IBDEI0SY ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,13027,1,4,0)
;;=4^H10.32
;;^UTILITY(U,$J,358.3,13027,2)
;;=^5133459
;;^UTILITY(U,$J,358.3,13028,0)
;;=H10.31^^51^627^14
;;^UTILITY(U,$J,358.3,13028,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13028,1,3,0)
;;=3^Conjunctivitis,Acute,Rt Eye
;;^UTILITY(U,$J,358.3,13028,1,4,0)
;;=4^H10.31
;;^UTILITY(U,$J,358.3,13028,2)
;;=^5133458
;;^UTILITY(U,$J,358.3,13029,0)
;;=H02.829^^51^627^15
;;^UTILITY(U,$J,358.3,13029,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13029,1,3,0)
;;=3^Cysts,Unspec Eyelid
;;^UTILITY(U,$J,358.3,13029,1,4,0)
;;=4^H02.829
;;^UTILITY(U,$J,358.3,13029,2)
;;=^5133442
;;^UTILITY(U,$J,358.3,13030,0)
;;=H02.834^^51^627^21
;;^UTILITY(U,$J,358.3,13030,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13030,1,3,0)
;;=3^Dermatochalasis,Lt Upper Eyelid
;;^UTILITY(U,$J,358.3,13030,1,4,0)
;;=4^H02.834
;;^UTILITY(U,$J,358.3,13030,2)
;;=^5004421
;;^UTILITY(U,$J,358.3,13031,0)
;;=H02.831^^51^627^22
;;^UTILITY(U,$J,358.3,13031,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13031,1,3,0)
;;=3^Dermatochalasis,Rt Upper Eyelid
;;^UTILITY(U,$J,358.3,13031,1,4,0)
;;=4^H02.831
;;^UTILITY(U,$J,358.3,13031,2)
;;=^5004418
;;^UTILITY(U,$J,358.3,13032,0)
;;=H04.123^^51^627^23
;;^UTILITY(U,$J,358.3,13032,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13032,1,3,0)
;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
;;^UTILITY(U,$J,358.3,13032,1,4,0)
;;=4^H04.123
;;^UTILITY(U,$J,358.3,13032,2)
;;=^5004465
;;^UTILITY(U,$J,358.3,13033,0)
;;=H02.135^^51^627^24
;;^UTILITY(U,$J,358.3,13033,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13033,1,3,0)
;;=3^Ectropion,Senile,Lt Lower Eyelid
;;^UTILITY(U,$J,358.3,13033,1,4,0)
;;=4^H02.135
;;^UTILITY(U,$J,358.3,13033,2)
;;=^5133414
;;^UTILITY(U,$J,358.3,13034,0)
;;=H02.132^^51^627^25
;;^UTILITY(U,$J,358.3,13034,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13034,1,3,0)
;;=3^Ectropion,Senile,Rt Lower Eyelid
;;^UTILITY(U,$J,358.3,13034,1,4,0)
;;=4^H02.132
;;^UTILITY(U,$J,358.3,13034,2)
;;=^5004318
;;^UTILITY(U,$J,358.3,13035,0)
;;=H35.3210^^51^627^30
;;^UTILITY(U,$J,358.3,13035,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13035,1,3,0)
;;=3^Exudative AMD,Rt Eye
;;^UTILITY(U,$J,358.3,13035,1,4,0)
;;=4^H35.3210
;;^UTILITY(U,$J,358.3,13035,2)
;;=^5138520
;;^UTILITY(U,$J,358.3,13036,0)
;;=H35.3220^^51^627^29
;;^UTILITY(U,$J,358.3,13036,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13036,1,3,0)
;;=3^Exudative AMD,Lt Eye
;;^UTILITY(U,$J,358.3,13036,1,4,0)
;;=4^H35.3220
;;^UTILITY(U,$J,358.3,13036,2)
;;=^5138524
;;^UTILITY(U,$J,358.3,13037,0)
;;=H20.00^^51^627^33
;;^UTILITY(U,$J,358.3,13037,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13037,1,3,0)
;;=3^Iridocyclitis,Acute/Subacute,Unspec
;;^UTILITY(U,$J,358.3,13037,1,4,0)
;;=4^H20.00
;;^UTILITY(U,$J,358.3,13037,2)
;;=^5005133
;;^UTILITY(U,$J,358.3,13038,0)
;;=H02.204^^51^627^34
;;^UTILITY(U,$J,358.3,13038,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13038,1,3,0)
;;=3^Lagophthalmos,Unspec,Lt Upper Eyelid,Unspec
;;^UTILITY(U,$J,358.3,13038,1,4,0)
;;=4^H02.204
;;^UTILITY(U,$J,358.3,13038,2)
;;=^5004330
;;^UTILITY(U,$J,358.3,13039,0)
;;=H02.201^^51^627^35
;;^UTILITY(U,$J,358.3,13039,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13039,1,3,0)
;;=3^Lagophthalmos,Unspec,Rt Upper Eyelid,Unspec
;;^UTILITY(U,$J,358.3,13039,1,4,0)
;;=4^H02.201
;;^UTILITY(U,$J,358.3,13039,2)
;;=^5004327
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0SY 3789 printed Sep 23, 2025@19:31:09 Page 2
IBDEI0SY ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,13027,1,4,0)
+2 ;;=4^H10.32
+3 ;;^UTILITY(U,$J,358.3,13027,2)
+4 ;;=^5133459
+5 ;;^UTILITY(U,$J,358.3,13028,0)
+6 ;;=H10.31^^51^627^14
+7 ;;^UTILITY(U,$J,358.3,13028,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,13028,1,3,0)
+10 ;;=3^Conjunctivitis,Acute,Rt Eye
+11 ;;^UTILITY(U,$J,358.3,13028,1,4,0)
+12 ;;=4^H10.31
+13 ;;^UTILITY(U,$J,358.3,13028,2)
+14 ;;=^5133458
+15 ;;^UTILITY(U,$J,358.3,13029,0)
+16 ;;=H02.829^^51^627^15
+17 ;;^UTILITY(U,$J,358.3,13029,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,13029,1,3,0)
+20 ;;=3^Cysts,Unspec Eyelid
+21 ;;^UTILITY(U,$J,358.3,13029,1,4,0)
+22 ;;=4^H02.829
+23 ;;^UTILITY(U,$J,358.3,13029,2)
+24 ;;=^5133442
+25 ;;^UTILITY(U,$J,358.3,13030,0)
+26 ;;=H02.834^^51^627^21
+27 ;;^UTILITY(U,$J,358.3,13030,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,13030,1,3,0)
+30 ;;=3^Dermatochalasis,Lt Upper Eyelid
+31 ;;^UTILITY(U,$J,358.3,13030,1,4,0)
+32 ;;=4^H02.834
+33 ;;^UTILITY(U,$J,358.3,13030,2)
+34 ;;=^5004421
+35 ;;^UTILITY(U,$J,358.3,13031,0)
+36 ;;=H02.831^^51^627^22
+37 ;;^UTILITY(U,$J,358.3,13031,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,13031,1,3,0)
+40 ;;=3^Dermatochalasis,Rt Upper Eyelid
+41 ;;^UTILITY(U,$J,358.3,13031,1,4,0)
+42 ;;=4^H02.831
+43 ;;^UTILITY(U,$J,358.3,13031,2)
+44 ;;=^5004418
+45 ;;^UTILITY(U,$J,358.3,13032,0)
+46 ;;=H04.123^^51^627^23
+47 ;;^UTILITY(U,$J,358.3,13032,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,13032,1,3,0)
+50 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
+51 ;;^UTILITY(U,$J,358.3,13032,1,4,0)
+52 ;;=4^H04.123
+53 ;;^UTILITY(U,$J,358.3,13032,2)
+54 ;;=^5004465
+55 ;;^UTILITY(U,$J,358.3,13033,0)
+56 ;;=H02.135^^51^627^24
+57 ;;^UTILITY(U,$J,358.3,13033,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,13033,1,3,0)
+60 ;;=3^Ectropion,Senile,Lt Lower Eyelid
+61 ;;^UTILITY(U,$J,358.3,13033,1,4,0)
+62 ;;=4^H02.135
+63 ;;^UTILITY(U,$J,358.3,13033,2)
+64 ;;=^5133414
+65 ;;^UTILITY(U,$J,358.3,13034,0)
+66 ;;=H02.132^^51^627^25
+67 ;;^UTILITY(U,$J,358.3,13034,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,13034,1,3,0)
+70 ;;=3^Ectropion,Senile,Rt Lower Eyelid
+71 ;;^UTILITY(U,$J,358.3,13034,1,4,0)
+72 ;;=4^H02.132
+73 ;;^UTILITY(U,$J,358.3,13034,2)
+74 ;;=^5004318
+75 ;;^UTILITY(U,$J,358.3,13035,0)
+76 ;;=H35.3210^^51^627^30
+77 ;;^UTILITY(U,$J,358.3,13035,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,13035,1,3,0)
+80 ;;=3^Exudative AMD,Rt Eye
+81 ;;^UTILITY(U,$J,358.3,13035,1,4,0)
+82 ;;=4^H35.3210
+83 ;;^UTILITY(U,$J,358.3,13035,2)
+84 ;;=^5138520
+85 ;;^UTILITY(U,$J,358.3,13036,0)
+86 ;;=H35.3220^^51^627^29
+87 ;;^UTILITY(U,$J,358.3,13036,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,13036,1,3,0)
+90 ;;=3^Exudative AMD,Lt Eye
+91 ;;^UTILITY(U,$J,358.3,13036,1,4,0)
+92 ;;=4^H35.3220
+93 ;;^UTILITY(U,$J,358.3,13036,2)
+94 ;;=^5138524
+95 ;;^UTILITY(U,$J,358.3,13037,0)
+96 ;;=H20.00^^51^627^33
+97 ;;^UTILITY(U,$J,358.3,13037,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,13037,1,3,0)
+100 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
+101 ;;^UTILITY(U,$J,358.3,13037,1,4,0)
+102 ;;=4^H20.00
+103 ;;^UTILITY(U,$J,358.3,13037,2)
+104 ;;=^5005133
+105 ;;^UTILITY(U,$J,358.3,13038,0)
+106 ;;=H02.204^^51^627^34
+107 ;;^UTILITY(U,$J,358.3,13038,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,13038,1,3,0)
+110 ;;=3^Lagophthalmos,Unspec,Lt Upper Eyelid,Unspec
+111 ;;^UTILITY(U,$J,358.3,13038,1,4,0)
+112 ;;=4^H02.204
+113 ;;^UTILITY(U,$J,358.3,13038,2)
+114 ;;=^5004330
+115 ;;^UTILITY(U,$J,358.3,13039,0)
+116 ;;=H02.201^^51^627^35
+117 ;;^UTILITY(U,$J,358.3,13039,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,13039,1,3,0)
+120 ;;=3^Lagophthalmos,Unspec,Rt Upper Eyelid,Unspec
+121 ;;^UTILITY(U,$J,358.3,13039,1,4,0)
+122 ;;=4^H02.201
+123 ;;^UTILITY(U,$J,358.3,13039,2)
+124 ;;=^5004327
